Press releases and articles

EUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies

EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the SARS-CoV-2 NeutraLISA assay, a surrogate neutralization test intended for the detection of neutralizing antibodies against ...

EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics

EUROIMMUN, a PerkinElmer, Inc. company, today announced the launch of the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the ...

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected COVID-19-Patients

New PCR test to differentiate between COVID-19 and flu

EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of SARS-CoV-2, influenza virus type A and influenza virus ...

Novel ELISA for Quantification of Antibodies against S1 Protein of SARS-CoV-2

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein.
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and ...

INOCHEM becomes part of EUROIMMUN family

INOCHEM, S.A. DE C.V., a provider of highly specialized tests for accurate diagnostics in clinical laboratories and hospitals in the public and private segments in Mexico, is now part of EUROIMMUN. ...

EURORealTime SARS-CoV-2 approved by the FDA via an Emergency Use Authorization

Subsequent to the EUROIMMUN-Anti-SARS-CoV-2 ELISA (IgG), the EURORealTime SARS-CoV-2 for direct pathogen detection has now also been approved for use in authorised laboratories by the U.S. American ...

SARS-CoV-2 Testing from EUROIMMUN

EUROIMMUN UK, a subsidiary of EUROIMMUN AG, is based in London and has supported Public Health England (PHE) in establishing a serology assay for use in the National Testing Strategy since March with ...

FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies

WALTHAM, Mass.--(BUSINESS WIRE)--May 5, 2020-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration ...

Back to top